Literature DB >> 23564909

Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets.

Peipei Mou1, Zhao Zeng, Qiang Li, Xiaohui Liu, Xiaoran Xin, Kenneth M Wannemacher, Changgeng Ruan, Renhao Li, Lawrence F Brass, Li Zhu.   

Abstract

Semaphorin 4D (Sema4D) is a transmembrane protein that supports contact-dependent amplification of platelet activation by collagen before being gradually cleaved by the metalloprotease ADAM17, as we have previously shown. Cleavage releases a soluble 120-kDa exodomain fragment for which receptors exist on platelets and endothelial cells. Here we have examined the mechanism that regulates Sema4D exodomain cleavage. The results show that the membrane-proximal cytoplasmic domain of Sema4D contains a binding site for calmodulin within the polybasic region Arg762-Lys779. Coprecipitation studies show that Sema4D and calmodulin are associated in resting platelets, forming a complex that dissociates upon platelet activation by the agonists that trigger Sema4D cleavage. Inhibiting calmodulin with W7 or introducing a membrane-permeable peptide corresponding to the calmodulin-binding site is sufficient to trigger the dissociation of Sema4D from calmodulin and initiate cleavage. Conversely, deletion of the calmodulin-binding site causes constitutive shedding of Sema4D. These results show that (1) Sema4D is a calmodulin-binding protein with a site of interaction in its membrane-proximal cytoplasmic domain, (2) platelet agonists cause dissociation of the calmodulin-Sema4D complex, and (3) dissociation of the complex is sufficient to trigger ADAM17-dependent cleavage of Sema4D, releasing a bioactive fragment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23564909      PMCID: PMC3656454          DOI: 10.1182/blood-2012-11-470609

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D.

Authors:  Christopher A Love; Karl Harlos; Nasim Mavaddat; Simon J Davis; David I Stuart; E Yvonne Jones; Robert M Esnouf
Journal:  Nat Struct Biol       Date:  2003-09-07

2.  Interplay between scatter factor receptors and B plexins controls invasive growth.

Authors:  Paolo Conrotto; Simona Corso; Sara Gamberini; Paolo Maria Comoglio; Silvia Giordano
Journal:  Oncogene       Date:  2004-07-01       Impact factor: 9.867

3.  [Preparation and identification of monoclonal antibodies against CD100 molecule].

Authors:  Xiao-guang Xu; Yong Zhu; Xue-song Liu; Ying Tian; Yun-xin Cao; Yi Hu; Bo-quan Jin
Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi       Date:  2003-01

4.  Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation.

Authors:  C Bougeret; I G Mansur; H Dastot; M Schmid; G Mahouy; A Bensussan; L Boumsell
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

5.  Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.

Authors:  K T Hall; L Boumsell; J L Schultze; V A Boussiotis; D M Dorfman; A A Cardoso; A Bensussan; L M Nadler; G J Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Identification of a novel transmembrane semaphorin expressed on lymphocytes.

Authors:  T Furuyama; S Inagaki; A Kosugi; S Noda; S Saitoh; M Ogata; Y Iwahashi; N Miyazaki; T Hamaoka; M Tohyama
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

7.  Solution structure of calmodulin-W-7 complex: the basis of diversity in molecular recognition.

Authors:  M Osawa; M B Swindells; J Tanikawa; T Tanaka; T Mase; T Furuya; M Ikura
Journal:  J Mol Biol       Date:  1998-02-13       Impact factor: 5.469

8.  A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen.

Authors:  C G Ruan; X P Du; X D Xi; P A Castaldi; M C Berndt
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

9.  Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B.

Authors:  John R Basile; Ana Barac; Tianqing Zhu; Kun-Liang Guan; J Silvio Gutkind
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

10.  The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras.

Authors:  Izumi Oinuma; Yukio Ishikawa; Hironori Katoh; Manabu Negishi
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

View more
  13 in total

1.  Semaphorin4D-PlexinB1 Signaling Attenuates Photoreceptor Outer Segment Phagocytosis by Reducing Rac1 Activity of RPE Cells.

Authors:  Ayelen Bulloj; Arvydas Maminishkis; Masayuki Mizui; Silvia C Finnemann
Journal:  Mol Neurobiol       Date:  2017-06-17       Impact factor: 5.590

2.  Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer.

Authors:  Wu-Gui Chen; Jing Sun; Wei-Wei Shen; Si-Zhen Yang; Ying Zhang; Xu Hu; Hao Qiu; Shang-Cheng Xu; Tong-Wei Chu
Journal:  Clin Exp Metastasis       Date:  2019-01-07       Impact factor: 5.150

Review 3.  Transmembrane semaphorins: Multimodal signaling cues in development and cancer.

Authors:  Sreeharsha Gurrapu; Luca Tamagnone
Journal:  Cell Adh Migr       Date:  2016-06-13       Impact factor: 3.405

4.  Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.

Authors:  Bo Chen; Donghong Sun; Xiuni Qin; Xing-Hua Gao
Journal:  Invest New Drugs       Date:  2021-01-26       Impact factor: 3.850

5.  Glaucocalyxin A inhibits platelet activation and thrombus formation preferentially via GPVI signaling pathway.

Authors:  Wei Li; Xiaorong Tang; Wenxiu Yi; Qiang Li; Lijie Ren; Xiaohui Liu; Chunjun Chu; Yukio Ozaki; Jian Zhang; Li Zhu
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

6.  Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.

Authors:  Wenxiu Yi; Qiang Li; Jian Shen; Lijie Ren; Xiaohui Liu; Qi Wang; Sudan He; Qingyu Wu; Hu Hu; Xinliang Mao; Li Zhu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

7.  Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.

Authors:  Yuji Yoshida; Atsushi Ogata; Sujin Kang; Kousuke Ebina; Kenrin Shi; Satoshi Nojima; Tetsuya Kimura; Daisuke Ito; Keiko Morimoto; Masayuki Nishide; Takashi Hosokawa; Toru Hirano; Yoshihito Shima; Masashi Narazaki; Hideki Tsuboi; Yukihiko Saeki; Tetsuya Tomita; Toshio Tanaka; Atsushi Kumanogoh
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

8.  Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways.

Authors:  Hongchao Jiang; Jiaolian Tang; Lijuan Qiu; Zhen Zhang; Shulan Shi; Li Xue; Liyue Kui; Tilong Huang; Weiwei Nan; Bailing Zhou; Canchun Zhao; Ming Yu; Qiangming Sun
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

Review 9.  Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.

Authors:  Alexandra L Matthews; Peter J Noy; Jasmeet S Reyat; Michael G Tomlinson
Journal:  Platelets       Date:  2016-06-02       Impact factor: 3.862

Review 10.  Modulation of Immune Responses by Platelet-Derived ADAM10.

Authors:  Stefanie Maurer; Hans-Georg Kopp; Helmut R Salih; Korbinian N Kropp
Journal:  Front Immunol       Date:  2020-02-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.